Health In Tech, Inc. Class A (HIT) Price & Analysis

Compare

67 Followers

HIT Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.51 - $7.59

Previous Close$5.45

Volume837.31K

Average Volume (3M)1.57M

Market Cap

$9.36M

Enterprise Value$40.99M

Total Cash (Recent Filing)$8.14M

Total Debt (Recent Filing)$174.36K

Price to Earnings (P/E)135.2

Beta1.80

Next Earnings

Mar 23, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.01

Shares Outstanding44,689,290

10 Day Avg. Volume1,192,748

30 Day Avg. Volume1,570,855

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap4.38

Enterprise Value/Revenue1.54

Enterprise Value/Gross Profit2.16

Enterprise Value/Ebitda16.25

Forecast

1Y Price Target

$3.25

Price Target Upside-1.52% Downside

Rating ConsensusModerate Buy

Number of Analyst Covering1

Bulls Say, Bears Say

Bulls Say

Financial HealthThe company ended June with $8.1M in cash and no debt, indicating it can fund operations without the need to raise capital.

Market Reach ExpansionHealth In Tech is expanding its underwriting platform to mid-size employers, indicating potential growth in the company's market reach.

Revenue GrowthHealth In Tech reported revenue of $9.3M, up 86% year-over-year, significantly surpassing estimates.

Bears Say

Future EBITDA Decline2025 adjusted EBITDA is projected to decline year-over-year due to public company costs.

Gross Margin Decline2Q25 gross margin declined to 67.7% compared to 80.5% in the prior-year quarter due to the cost of utilizing distribution partners.

Health In Tech, Inc. Class A News

Health In Tech regains Nasdaq compliance

Health In Tech (HIT) announced that it received formal written confirmation from The Nasdaq Stock Market confirming that...

27d ago

HIT

Health In Tech announces partnership with Verdegard Administrators

Health In Tech (HIT) is proud to announce a new collaboration with Verdegard Administrators, a licensed third-party administrator...

27d ago

HIT

Health In Tech reports Q2 EPS 1c vs. 1c last year

Reports Q2 revenue $9.3M vs. $5.00M last year. “We delivered another strong quarter of profitable growth, with total...

30d ago

HIT

Health In Tech Grants Stock Awards to Executives

The latest update is out from Health In Tech, Inc. Class A ( ($HIT) ). On August 15,...

1d ago

HIT

Health In Tech, Inc. Reports Strong Q2 Growth

Health In Tech, Inc. Class A (($HIT)) has held its Q2 earnings call. Read on for the main...

28d ago

HIT

Health In Tech Reports Strong Q2 2025 Growth

Health In Tech, Inc. Class A ( ($HIT) ) has released its Q2 earnings. Here is a breakdown...

29d ago

HIT

Health In Tech Reports Strong Q2 2025 Growth

Health In Tech, Inc. Class A ( ($HIT) ) has issued an update. On July 21, 2025, Health...

30d ago

HIT

Health In Tech Reports Robust Q2 2025 Financial Growth

The latest announcement is out from Health In Tech, Inc. Class A ( ($HIT) ). On July 21,...

30d ago

HIT

Health In Tech, Inc. Class A (HIT) Q2 Earnings Cheat Sheet

Health In Tech, Inc. Class A (HIT) is scheduled to report 2nd quarter earnings on 07/21/2025, after the...

1M ago

HIT

Health In Tech initiated with a Buy at Maxim

Maxim initiated coverage of Health In Tech (HIT) with a Buy rating and $2.50 price target The company...

2M ago

HIT

Health In Tech initiated with a Buy at Maxim

Maxim initiated coverage of Health In Tech (HIT) with a Buy rating and $2.50 price target Published first...

2M ago

HIT

Health In Tech Reports Strong Growth Amid Strategic Advances

Health In Tech, Inc. Class A (($HIT)) has held its Q1 earnings call. Read on for the main...

4M ago

HIT

Health In Tech Board Restructures After Liang Resignation

The latest announcement is out from Health In Tech, Inc. Class A ( ($HIT) ). On April 12,...

4M ago

HIT

Health In Tech Reports Strong Q1 2025 Growth

Health In Tech, Inc. Class A ( ($HIT) ) has released its Q1 earnings. Here is a breakdown...

4M ago

HIT

HIT FAQ

What was Health In Tech, Inc. Class A’s price range in the past 12 months?

Health In Tech, Inc. Class A lowest stock price was $0.51 and its highest was $7.59 in the past 12 months.

What is Health In Tech, Inc. Class A’s market cap?

Health In Tech, Inc. Class A’s market cap is $9.36M.

When is Health In Tech, Inc. Class A’s upcoming earnings report date?

Health In Tech, Inc. Class A’s upcoming earnings report date is Mar 23, 2026 which is in 215 days.

How were Health In Tech, Inc. Class A’s earnings last quarter?

Health In Tech, Inc. Class A released its earnings results on Jul 21, 2025. The company reported $0.01 earnings per share for the quarter, the consensus estimate of $0.01 by $0.

Is Health In Tech, Inc. Class A overvalued?

According to Wall Street analysts Health In Tech, Inc. Class A’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Health In Tech, Inc. Class A pay dividends?

Health In Tech, Inc. Class A does not currently pay dividends.

What is Health In Tech, Inc. Class A’s EPS estimate?

Health In Tech, Inc. Class A’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Health In Tech, Inc. Class A have?

Health In Tech, Inc. Class A has 44,689,290 shares outstanding.

What happened to Health In Tech, Inc. Class A’s price movement after its last earnings report?

Health In Tech, Inc. Class A reported an EPS of $0.01 in its last earnings report, expectations of $0.01. Following the earnings report the stock price went up 25.185%.

Which hedge fund is a major shareholder of Health In Tech, Inc. Class A?

Currently, no hedge funds are holding shares in HIT

Company Description

Health In Tech, Inc. Class A

Health In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small to medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.

Health In Tech, Inc. Class A (HIT) Earnings & Revenues

Historic Earnings Reports

HIT Company Deck

HIT Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call reflected a strong positive outlook for Health in Tech, with significant revenue growth, strategic expansion, and improved profitability metrics outweighing the increase in general administrative expenses.View all HIT earnings summaries

HIT Stock 12 Month Forecast

Average Price Target

$3.25

▼(-1.52% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"$8","-1":"-$1","1.25":"$1.25","3.5":"$3.5","5.75":"$5.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$3.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$3.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.25</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,1.25,3.5,5.75,8],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2,2.0961538461538463,2.1923076923076925,2.2884615384615383,2.3846153846153846,2.480769230769231,2.576923076923077,2.6730769230769234,2.769230769230769,2.8653846153846154,2.9615384615384617,3.0576923076923075,3.153846153846154,{"y":3.25,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2,2.0961538461538463,2.1923076923076925,2.2884615384615383,2.3846153846153846,2.480769230769231,2.576923076923077,2.6730769230769234,2.769230769230769,2.8653846153846154,2.9615384615384617,3.0576923076923075,3.153846153846154,{"y":3.25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2,2.0961538461538463,2.1923076923076925,2.2884615384615383,2.3846153846153846,2.480769230769231,2.576923076923077,2.6730769230769234,2.769230769230769,2.8653846153846154,2.9615384615384617,3.0576923076923075,3.153846153846154,{"y":3.25,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.5,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.5,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.5,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.5,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.36,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.52,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":7.05,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.69,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.69,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.61,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.63,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.84,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >